This model contributed a deeper understanding of the pathological mechanisms of clinical impairment caused by white matter damage in patients with a new PD subtype, and these findings associated with the reduced DAT uptake in the left putamen in this study may offer new perspectives for clinical intervention strategies. The gene discussed is SLC6A3; the disease is Parkinson disease.